Serum Levels of Stem Cell Factor for Predicting Embryo Quality

Overview

Journal Sci Rep

Specialty Science

Date 2024 May 22

PMID 38778076

Authors

Joanna Liss

Martyna Kuczynska

Michal Kunicki

Krystian Zielinski

Damian Drzyzga

Affiliations

Soon will be listed here.

Abstract

We evaluated whether serum stem cell factor (s-SCF) levels just prior to ovulation induction could indicate the ability to develop a top-quality (TQ) blastocyst by day 5. We investigated patients with normal ovarian reserve (NOR), polycystic ovary syndrome (PCOS), diminished ovarian reserve (DOR), or mild endometriosis. Our pilot research suggests a correlation between s-SCF levels and the ability to form TQ blastocysts in patients with mild endometriosis. This significant statistical difference (p < 0.05) was noted between mild endometriosis patients for whom a TQ blastocyst was obtained and those for whom it was not possible, as measured on the 8th day of stimulation and the day of oocyte retrieval. The mean SCF levels in the serum of these women on the 8th day were at 28.07 (± 2.67) pg/ml for the TQ subgroup and 53.32 (± 16.02) pg/ml for the non-TQ subgroup (p < 0.05). On oocyte retrieval day it was 33.47 (± 3.93) pg/ml and 52.23 (± 9.72) pg/ml (p < 0.05), respectively.

References

Ferraretti A, La Marca A, Fauser B, Tarlatzis B, Nargund G, Gianaroli L . ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011; 26(7):1616-24. DOI: 10.1093/humrep/der092. View

Tan J, Zou Y, Wu X, Tian L, Su Q, He J . Increased SCF in Follicular Fluid and Granulosa Cells Positively Correlates With Oocyte Maturation, Fertilization, and Embryo Quality in Humans. Reprod Sci. 2017; 24(11):1544-1550. DOI: 10.1177/1933719117697125. View

Osuga Y, Hirota Y, Taketani Y . Basic and translational research on proteinase-activated receptors: proteinase-activated receptors in female reproductive tissues and endometriosis. J Pharmacol Sci. 2008; 108(4):422-5. DOI: 10.1254/jphs.08r13fm. View

Vermey B, Chua S, Zafarmand M, Wang R, Longobardi S, Cottell E . Is there an association between oocyte number and embryo quality? A systematic review and meta-analysis. Reprod Biomed Online. 2019; 39(5):751-763. DOI: 10.1016/j.rbmo.2019.06.013. View

Gizzo S, Andrisani A, Esposito F, Oliva A, Zicchina C, Capuzzo D . Ovarian reserve test: an impartial means to resolve the mismatch between chronological and biological age in the assessment of female reproductive chances. Reprod Sci. 2013; 21(5):632-9. DOI: 10.1177/1933719113508821. View

Franco-Murillo Y, Miranda-Rodriguez J, Rendon-Huerta E, Montano L, Cornejo G, Gomez L . Unremitting cell proliferation in the secretory phase of eutopic endometriosis: involvement of pAkt and pGSK3β. Reprod Sci. 2014; 22(4):502-10. PMC: 4812691. DOI: 10.1177/1933719114549843. View

Figueira M, Cardoso H, Correia S, Maia C, Socorro S . Hormonal regulation of c-KIT receptor and its ligand: implications for human infertility?. Prog Histochem Cytochem. 2014; 49(1-3):1-19. DOI: 10.1016/j.proghi.2014.09.001. View

Josso N . WOMEN IN REPRODUCTIVE SCIENCE: Anti-Müllerian hormone: a look back and ahead. Reproduction. 2019; 158(6):F81-F89. DOI: 10.1530/REP-18-0602. View

Hirshfield A . Development of follicles in the mammalian ovary. Int Rev Cytol. 1991; 124:43-101. DOI: 10.1016/s0074-7696(08)61524-7. View

10.

Makker A, Goel M, Mahdi A . PI3K/PTEN/Akt and TSC/mTOR signaling pathways, ovarian dysfunction, and infertility: an update. J Mol Endocrinol. 2014; 53(3):R103-18. DOI: 10.1530/JME-14-0220. View

11.

Zhang J, Yu C, Yan L, Ma J . Effect of anti-mullerian hormone on stem cell factor in serum, follicular fluid and ovarian granular cells of polycystic ovarian syndrome patients. Eur Rev Med Pharmacol Sci. 2018; 22(22):7877-7882. DOI: 10.26355/eurrev_201811_16413. View

12.

Fu Y, Wang F, Ou-Yang X, Yang H, Hu T, Wang Y . Anti-Müllerian Hormone Regulates Stem Cell Factor via cAMP/PKA Signaling Pathway in Human Granulosa Cells by Inhibiting the Phosphorylation of CREB. Reprod Sci. 2020; 27(1):325-333. DOI: 10.1007/s43032-019-00033-4. View

13.

Guo Z, Yu Q . Role of mTOR Signaling in Female Reproduction. Front Endocrinol (Lausanne). 2019; 10:692. PMC: 6794368. DOI: 10.3389/fendo.2019.00692. View

14.

Johnson N, Hummelshoj L, Adamson G, Keckstein J, Taylor H, Abrao M . World Endometriosis Society consensus on the classification of endometriosis. Hum Reprod. 2016; 32(2):315-324. DOI: 10.1093/humrep/dew293. View

15.

Reddy P, Shen L, Ren C, Boman K, Lundin E, Ottander U . Activation of Akt (PKB) and suppression of FKHRL1 in mouse and rat oocytes by stem cell factor during follicular activation and development. Dev Biol. 2005; 281(2):160-70. DOI: 10.1016/j.ydbio.2005.02.013. View

16.

Salmassi A, Zorn S, Mettler L, Koch K, Jonat W, Schmutzler A . Circulating concentration of stem cell factor in serum of stimulated IVF patients. Reprod Biomed Online. 2011; 22(2):140-7. DOI: 10.1016/j.rbmo.2010.10.008. View

17.

Osuga Y, Koga K, Tsutsumi O, Igarashi T, Okagaki R, Takai Y . Stem cell factor (SCF) concentrations in peritoneal fluid of women with or without endometriosis. Am J Reprod Immunol. 2000; 44(4):231-5. DOI: 10.1111/j.8755-8920.2000.440407.x. View

18.

Hutt K, McLaughlin E, Holland M . KIT/KIT ligand in mammalian oogenesis and folliculogenesis: roles in rabbit and murine ovarian follicle activation and oocyte growth. Biol Reprod. 2006; 75(3):421-33. DOI: 10.1095/biolreprod.106.051516. View

19.

. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2003; 19(1):41-7. DOI: 10.1093/humrep/deh098. View

20.

Azziz R, Carmina E, Chen Z, Dunaif A, Laven J, Legro R . Polycystic ovary syndrome. Nat Rev Dis Primers. 2016; 2:16057. DOI: 10.1038/nrdp.2016.57. View